Showing results (1601-1610 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|September 29, 2020
Quetiapine Relieved Pisa Syndrome in Patient With Parkinson DiseaseJunwu Zhao, Quan Wang, Hairong Sun, et al.Clinical Neuropharmacology|December 1, 2018
Bupropion-Related Exacerbation of Tic Disorder in an Adult: A Case ReportIdo Lurie, Ori Ganor, Gad MayerClinical Neuropharmacology|December 1, 2018
New Daily Persistent Headache and OnabotulinumtoxinA TherapyAshhar Ali, Jennifer Kriegler, Stewart Tepper, et al.Clinical Neuropharmacology|February 13, 2019
Postinjection Delirium/Sedation Syndrome After 31st Long-Acting Olanzapine Depot InjectionVelprashanth Venkatesan, Sourav Khanra, Kamalika Mandal, et al.Clinical Neuropharmacology|March 29, 2020
Life-Threatening Serotonin Syndrome Precipitated by Discontinuation of Serotonin-Dopamine Antagonist in the Presence of Serotonergic Agents: A Case ReportTakuto Ishida, Hiroyuki Uchida, Satoru Kaneko, et al.Clinical Neuropharmacology|March 29, 2020
Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case SeriesLamia Sid-Otmane, Philippe Huot, Michel PanissetClinical Neuropharmacology|June 23, 2016
Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic HypotensionRobert A Hauser, Stephane Heritier, Gerald J Rowse, et al.Clinical Neuropharmacology|June 23, 2016
Transdermal Rivastigmine Delivery for Alzheimer Disease: Amenability of Exposure Predictions of Rivastigmine and Metabolite, NAP226-90, by Linear Regression Model Using Limited SamplesNuggehally R SrinivasClinical Neuropharmacology|September 18, 2020
Dextromethorphan Abuse Among Opioid-Dependent PatientsLaura G Windhab, Salome Gastberger, Lea M Hulka, et al.Clinical Neuropharmacology|September 18, 2020
Vitamin B6 Deficiency in Patients With Parkinson Disease Treated With Levodopa/CarbidopaAna Rojo-Sebastián, Cristina González-Robles, Justo García de YébenesPageof 237